JAKARTA (Yosefardi) – Pharmaceutical firm PT Merck Sharp Dohme Pharma Tbk (SCPI), formerly PT Schering-Plough Indonesia Tbk, is ready to be involved on BPJS Health (Social Insurance Implementing Body for Health) program.
However the company said it would only supply selective and limited products on the program implemented since January 1, 2014. The government will provide service to 140 million members (of the universal healthcare plan administered by the Body).
Merck booked net loss of Rp21.83 billion in first nine months of 2013, widened from loss of Rp112.04 billion in the same period of 2012. Sales declined 21.7% to Rp223.53 billion from previous Rp285.87 billion.